Özet:

The main objective of this study is to determine the patient’s awareness of the need for hepatitis B, influenza and pneumococcus vaccines in diabetic patients. Secondary purposes are to identify where patients who are aware of the need to take hepatitis B, influenza and pneumococcus vaccines and the source of information they have received (the doctor, TV, neighbor, etc.) It is intended to determine the effect on vaccination. Method: Diabetic patients who apply to the Diabetes-Obesite Clinic were asked to fill the Diabetes Vaccine Survey. Patients who agreed to fill the questionnaire filled the questionnaire with the help of the doctor in the necessary places. The completed data was completed. The study was conducted through the SPSS program. 318 patients participated in the study. The average age was 54.77 (61.9 percent women and 38.1 percent men). 90,9% of the patients lived in Ankara. 37.7 percent were primary school graduates, 28 percent were high school graduates, 28 percent were university graduates, while 5 percent were without reading and writing. 6.9% of patients were type 1 diabetes, while others were type 2 diabetes. The average diabetic period was 8.8 years. 46.3 percent of patients knew they needed flu vaccines, 18.9 percent of patients needed pneumococcus vaccines and 34.5 percent of patients needed hepatitis B vaccines. Patients received this information through the doctor’s recommendation. 72% of the flu vaccine group, 75% of the pneumococcus group and 71.6% of the hepatitis B group. The majority of the doctors who informed about the vaccine were family doctors, internal doctors and endocrinologists. (The common rates of the three doctors were 81.7% in the Influenza vaccine group, 76.8% in the pneumococcus vaccine group and 72.6% in the hepatitis B vaccine group.) As a source of information, television took the second place in all groups. 16.7% of the flu vaccine group, 19.6% of the pneumococcus vaccine group and 18.6% of the hepatitis B vaccine group. In all patients, the rate of people vaccinated against influenza was 14.6, the rate of people vaccinated against pneumococcus was 3.8, the rate of people vaccinated against hepatitis B was 15.5%. In the group of hepatitis B, the rate of vaccination was also observed with an increase in the study status. This relationship was not established in other groups. The information obtained was not observed to have an impact on the vaccination rates. In our study, the awareness and vaccination rates on the need for vaccination in diabetic patients were observed below the rates in developed countries. More healthcare is needed to increase these rates.